ClinicalTrials.govpublic full text
Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant
e coli infections, allogenic transplant patients
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 162522
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.